These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38158826)

  • 1. Risk Factors for SARS-CoV-2 Among a Cohort of Healthcare Workers in Lebanon.
    Sakr CJ; Abou Hassan FF; Fakih L; Bou Hamdan M; Assaf S; Rahme D; Melhem NM
    Workplace Health Saf; 2024 Feb; 72(2):48-59. PubMed ID: 38158826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    Martin CA; Pan D; Melbourne C; Teece L; Aujayeb A; Baggaley RF; Bryant L; Carr S; Gregary B; Gupta A; Guyatt AL; John C; McManus IC; Nazareth J; Nellums LB; Reza R; Simpson S; Tobin MD; Woolf K; Zingwe S; Khunti K; Abrams KR; Gray LJ; Pareek M;
    PLoS Med; 2022 May; 19(5):e1004015. PubMed ID: 35617423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
    Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
    BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.
    Taher WT; Bawazir AA; Sallam TA; Alsurimi K
    BMC Infect Dis; 2023 Nov; 23(1):761. PubMed ID: 37932664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
    Bansal A; Trieu MC; Mohn KGI; Madsen A; Olofsson JS; Sandnes HH; Sævik M; Søyland H; Hansen L; Onyango TB; Tøndel C; Brokstad KA; ; Syre H; Riis ÅG; Langeland N; Cox RJ
    Front Public Health; 2023; 11():1164326. PubMed ID: 37546332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.
    Reusch J; Wagenhäuser I; Gabel A; Eggestein A; Höhn A; Lâm TT; Frey A; Schubert-Unkmeir A; Dölken L; Frantz S; Kurzai O; Vogel U; Krone M; Petri N
    J Med Virol; 2023 Jan; 95(1):e28300. PubMed ID: 36369641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional study of SARS-CoV-2 antibodies among healthcare workers in a tertiary care hospital in Taiwan: implications for protection against the Omicron variants.
    Chen CH; Chao DY; Kor CT; Kuo SF; Lin JS; Lai HW; Liu YT; Lin CH; Chen MK
    BMC Infect Dis; 2024 May; 24(1):529. PubMed ID: 38802771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
    Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
    Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
    Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
    Front Public Health; 2022; 10():832003. PubMed ID: 35400056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt.
    El-Sokkary RH; Daef E; El-Korashi LA; Khedr EM; Gad D; Mohamed-Hussein A; Zayed NE; Mostafa EF; Bahgat SM; Hassany SM; Amer MG; El-Mokhtar MA; Elantouny NG; Hassan SA; Zarzour AA; Hashem MK; Amin MT; Hassan HM
    J Infect Public Health; 2021 Oct; 14(10):1474-1480. PubMed ID: 34556461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
    Basso P; Negro C; Cegolon L; Larese Filon F
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
    [No Abstract]   [Full Text] [Related]  

  • 19. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
    Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
    Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
    Stellini R; Gianello R; Gomarasca W
    Infection; 2022 Dec; 50(6):1573-1577. PubMed ID: 35391649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.